Pharmaceutical Sciences
Research Agricultural
Total number of Record(s): 127
| Title | Principal Investigator | Start Year | Funding Agency | Focus Area |
|---|---|---|---|---|
| A clinical drug development programme to evaluate and compare the safety and efficacy of new regimens of Lifecare's Liposomal Amphotericin b (FUNGISOMETM) against currently accepted therapies for the treatment of Kala Azar; A Phase III, Open Label Randomized Trial of Three Single Dose Treatment regimens of FUNGISOMETM ALONE OR IN Combination with Miltefosine compared with single Dose Treatment regimen of AmBisome for visceral Leishmaniasis in India | Dr. J N Verma, Lifecare Innovations Private Limited, Gurgaon, Haryana (122018) | 2024 | Department of Science and Technology (DST) | Pharmacology and Infectious Diseases |
| In silico discovery and biological evaluation of potential drug molecules to improve the treatment of Bedaquiline and Delamanid resistance in Mycobacterium tuberculosis. | Dr. Shalini Saxena, University of Hyderabad, Telangana (500046) | 2024 | Department of Science and Technology (DST) | Drug Discovery and Microbiology |
| pH-Responsive Biodegradable Nanogels for Controlled and Targeted Drug Delivery Systems | Ms. Sulagna Bhattacharjee, Tripura University (799022) | 2024 | Department of Science and Technology (DST) | Nanotechnology, Biomedical Engineering |
| Preparation and Characterization of Novel Formulations of Nepafenac for the Management of Ocular Inflammation. | Mrs. Deepshikha, University Institute Of Pharmaceutical Sciences, Panjab University, Chandigarh (160014) | 2024 | Department of Science and Technology (DST) | Health, Nepafenac for Ocular Inflammation |
| Targeting peroxisomal fatty acid oxidation to overcome resistance to therapy in breast cancer cells | Dr. Sudhagar S, Assistant Professor, National Institute of Pharmaceutical Education and Research (NIPER-G), Guwahati | 2024 | Biotechnology, Breast Cancer | |
| Bioprospecting the North-East Himalayan plants for its Cardioprotective activity through metabolomics approach | Prof. Radhakrishnanand Pullapanthula, National Institute of Pharmaceutical Education and Research (NIPER-G), Guwahati | 2023 | Pharmaceutical Analysis, Metabolomics | |
| Molecular explorations of the Leishmania donovani Homoserine Dehydrogenase and evaluating the impact of its perturbations using CRISPR-Cas9 system’’ | Dr. Sushma Singh, Associate Professor, National Institute of Pharmaceutical Education and Research (NIPER), | 2023 | Biotechnology, Molecular biology | |
| Understanding the impact of drug-herbal dietary supplements pharmacokinetic interactions: Integrated transcriptomics analysis to study the key metabolism, pathways, and safety evaluation | Dr. Satheeshkumar Nanjappan, Associate Professor, National Institute of Pharmaceutical Education and Research, Kolkata | 2023 | Natural products, Herbal Dietary Supplements | |
| Synthesis and evaluation of novel dual GSK-3β/HDAC inhibitor as an anti-Alzheimer agent | Dr. Abha Sharma, Associate Professor, National Institute of Pharmaceutical Education and Research, Raebareli | 2023 | Medicinal Chemistry, life sciences | |
| Development of micro-RNA (miRNA) responsive gene expression platforms for targeting Breast Cancer | Dr. Utpal Mohan, Assistant Professor, National Institute of Pharmaceutical Education and Research, Kolkata | 2023 | Medicinal Chemistry, Genetic Engineering |